Itron Inc. filings document the reporting, governance and capital-structure records of an operating company serving utility and city infrastructure markets. Recent 8-K disclosures cover operating results, financial-condition updates, material agreements and the issuance of convertible senior notes, including purchase agreement and indenture terms tied to the company’s debt and equity structure.
Proxy and shareholder-vote filings describe director elections, advisory executive-compensation votes and annual meeting matters for holders of Itron common stock. Other material-event filings record cybersecurity response and operational-continuity disclosures, while exchange-registration information identifies ITRI common stock, no par value, as listed on the Nasdaq Global Select Market.
Itron, Inc. director Sheri Savage acquired 608 shares of common stock on October 1, 2026, through a grant independent members of Itron's board receive quarterly as part of annual compensation for board service. Her directly held common stock following the grant was 2,995 shares.
Itron, Inc. director Santiago Perez acquired a grant of 608 shares of common stock on October 1, 2026, as part of the quarterly stock grants independent board members receive for board service. Direct holdings following the grant were 13,127 shares. The grant is described as part of annual compensation for board service.
Itron, Inc. (ITRI) director Sanjay Mirchandani received a grant of 608 common shares on October 1, 2026, as part of the quarterly stock compensation independent members receive for board service. The reported transaction price was $0.00 per share. His directly held common-stock position following the grant was 7,432 shares.
Itron, Inc. (ITRI) director Timothy M. Leyden received a grant of 243 common shares on October 1, 2026, as part of quarterly compensation for board service. He deferred receipt of 91 shares under Itron's Executive Deferred Compensation Plan. His reported direct holdings after the grant were 16,496 shares.
Itron, Inc. director Jerome J. Lande received a grant of 608 shares of common stock on October 1, 2026. This was a quarterly grant of common stock independent members of Itron’s board receive as part of annual compensation for board service. The reported transaction was an award, not a market purchase or sale. His direct common-stock holdings after the grant were 11,373 shares.
Itron, Inc. director Frank M. Jaehnert acquired a 608-share common-stock award on October 1, 2026. The award reflects the quarterly grant independent board members receive as annual compensation for board service; Jaehnert deferred receipt under Itron’s Executive Deferred Compensation Plan. His reported direct holdings following the transaction were 23,726 shares.
Itron, Inc. reported that director Scott D. Drury was granted 608 shares on October 1, 2026. The grant was part of quarterly common-stock compensation for independent board members. Drury deferred receipt under Itron’s Executive Deferred Compensation Plan, and the reported post-transaction position was 2,952 shares.
ITRON, INC. (ITRI) reported that Justin K. Patrick, its SVP, Device Solutions, sold a total of 10,210 shares of common stock on September 3, 2026 in multiple open-market transactions at a price of $97.36 per share. All reported sales were made under a Rule 10b5-1 trading plan adopted on May 6, 2026.
ITRON, INC. (ITRI) has a notice of proposed sale of common stock filed on behalf of officer Justin K. Patrick under Rule 144. The filing lists 10,210 shares of common stock to be sold through Fidelity Brokerage Services LLC, with an approximate aggregate value of $994,045.60 as of September 3, 2026.
The notice also reports that during the prior three months, Justin K. Patrick sold 212 shares on August 20, 2026 for $20,739.09 and 222 shares on August 24, 2026 for $21,931.38. The shares proposed for sale were acquired through multiple restricted stock vesting compensation grants from the issuer on various dates in 2024 and 2025.
ITRON, INC. (ITRI) insider Donald L. Reeves III, SVP, Outcomes, reported selling 283 shares of common stock on 2026-08-25 in an open-market transaction at $99.99 per share. The sale was made under a Rule 10b5-1 Trading Plan adopted on September 11, 2025, and he now holds 27,662 shares directly.